Last night, news broke that pharma giant Eli Lilly was in talks to acquire Verve Therapeutics.   After a 3-year lull in major CRISPR deal...

When Intellia Therapeutics set out to develop a CRISPR-based prekallikrein knockout for hereditary angioedema (HAE), it was as a compelling ...

There is now overwhelming evidence that the new US healthcare administration is serious in its mission of making its citizens inherently hea...

Prime editing researchers are so excited about the technology that sponsor Prime Medicine is unable to control the newsflow on their CGD tri...

Over the last couple of weeks, we have seen business development activities in the RNAi space that made me realize that the modality has fir...

 Last night, Intellia filed a material event report ( 8-k ) with the SEC.  In there, they revealed a case of very high, grade 4 liver enzyme...